Literature DB >> 26185918

Interconception Care Opportunities for Mom and Baby.

Julie Z DeCesare1, Jessica R Jackson2, Briana Phillips2.   

Abstract

IMPORTANCE: Interconception care provides an irreplaceable opportunity to address existing chronic disease and correct maladaptive health behaviors.
OBJECTIVE: Utilizing the postpartum visit as an opportunity to improve interconception health and provide education to patients will not only improve the patient's life, but also impact any future offspring. EVIDENCE ACQUISITION/
RESULTS: Optimization of interconception health has the potential to improve population wellbeing and reduce the societal burden poor birth outcomes. Evidence-based recommendations are described.

Entities:  

Mesh:

Year:  2015        PMID: 26185918     DOI: 10.1097/OGX.0000000000000196

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  4 in total

1.  Maternal Sociodemographic Characteristics, Experiences and Health Behaviors Associated with Postpartum Care Utilization: Evidence from Maryland PRAMS Dataset, 2012-2013.

Authors:  Isabel Morgan; Mary Elizabeth Hughes; Harolyn Belcher; Laurens Holmes
Journal:  Matern Child Health J       Date:  2018-04

2.  Non-communicable diseases and maternal health: a scoping review.

Authors:  Tabassum Firoz; Beth Pineles; Nishika Navrange; Alyssa Grimshaw; Olufemi Oladapo; Doris Chou
Journal:  BMC Pregnancy Childbirth       Date:  2022-10-22       Impact factor: 3.105

3.  Facilitators and Barriers for Successful Implementation of Interconception Care in Preventive Child Health Care Services in the Netherlands.

Authors:  Meertien K Sijpkens; Eric A P Steegers; Ageeth N Rosman
Journal:  Matern Child Health J       Date:  2016-11

4.  Integrating interconception care in preventive child health care services: The Healthy Pregnancy 4 All program.

Authors:  Meertien K Sijpkens; Jacqueline Lagendijk; Minke R C van Minde; Marlou L A de Kroon; Loes C M Bertens; Ageeth N Rosman; Eric A P Steegers
Journal:  PLoS One       Date:  2019-11-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.